Seqirus received FDA approval for AFLURIA® QUADRIVALENT (Influenza Vaccine) for people 18 years of age and older
On Aug. 29, 2016, Seqirus announced that the U.S. Food and Drug Administration (FDA) had approved AFLURIA® QUADRIVALENT…
On Aug. 29, 2016, Seqirus announced that the U.S. Food and Drug Administration (FDA) had approved AFLURIA® QUADRIVALENT…
On Aug. 26, 2016, the CDC published 2016ï¾–17 influenza vaccination recommendations.
On Jun. 22, 2016, the Centers for Disease Control and Prevention’s (CDC) Immunization Practices Advisory Committee (ACIP) voted…
On Nov. 25, 2015, Seqirus announced that the U.S. Food and Drug Administration (FDA) had approved Fluadâ„¢ (Influenza…
On Aug. 14, 2015, the World Health Organization (WHO) published “Recommendations on Vaccine Hesitancy” in a special issue…
On Dec. 22, 2014, Sanofi Pasteur announced the FDA had approved the supplemental biologics license application (sBLA) for…
On Dec. 22, 2014, BioCryst Pharmaceuticals announced the FDA had approved RAPIVAB (peramivir injection), an intravenous (i.v.) neuraminidase…
On Dec. 12, 2014, Sanofi Pasteur announced the FDA had approved the supplemental biologics license application (sBLA) for…
On Feb. 28, 2014, the U.S. Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee…
On Aug. 1, 2014, the U.S. Centers for Disease Control and Prevention (CDC) initiated the Global Heath Security…
On Jul. 2, 2013 the U.S. Centers for Disease Control and Prevention (CDC) partnered with Association of Public…
On Jun. 20, 2013, the Advisory Committee on Immunization Practices (ACIP) voted 13 to 0, in favor of…
On Jun. 7, 2013, Sanofi Pasteur announced the FDA had approved the supplemental biologics license application (sBLA) for…
On Mar. 26, 2013, GlaxoSmithKline and the Texas A&M University System announced that the U.S. Department of Health…
On Dec. 14, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved GlaxoSmithKline’s quadrivalent formulation…
On Nov. 20, 2012, the FDA approved a seasonal flu vaccine produced by Novartis using animal cell culture…
On Nov. 20, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved first seasonal influenza…
On Feb. 21, 2012, as part of a national collaboration, Oregon Health & Science University researchers were studying…
In 2012, vaccines containing cell-cultured virus became available. Even though eggs continued to be the primary means of…
On Dec. 30, 2011, Pfizer announced that the U.S. Food and Drug Administration (FDA) had granted approval of…
On Aug. 10, 2010, WHO Director-General Dr Margaret Chan announced that the H1N1 influenza virus had moved into…
On Feb. 24, 2010, the Immunization Practices Advisory Committee (ACIP) recommended universal Influenza vaccination for those 6 months…
On Jan. 29, 2010, the Bill and Melinda Gates announced that their foundation will commit $10 billion over…
On Dec. 23, 2009, the FDA approved high-dose inactivated influenza vaccine (Fluzone High-Dose) for people ages 65 years…
On Nov. 16, 2009, the U.S. Centers for Disease Control and Prevention (CDC) recommended a single dose of…
On Oct. 24, 2009, President Barack Obama declared the swine flu (N1n1) outbreak a national emergency. The declaration…
On Sept. 15, 2009, the U.S. Food and Drug Administration (FDA) approved four Influenza A (H1N1) 2009 Monovalent…
On Jul. 31, 2009, the Immunization Practices Advisory Committee (ACIP) updates the 2008 recommendations regarding the use of…
On Jun. 23, 2009, the U.S. Department of Health and Human Services (HHS) announced advanced development contract for…
On Jun. 11, 2009, the Dr. Margaret Chan, Director-General WHO, declared world now at the start of 2009…